Status:
COMPLETED
Microcurrent Treatment for Chronic Debilitating Pain
Lead Sponsor:
Paul Crawford
Conditions:
Pain
Opioid Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three ...
Detailed Description
This study is not intended to be definitive and should be considered an exploratory randomized trial to determine conditions for which microcurrent is more effective. Thus, extensive subgroup analyses...
Eligibility Criteria
Inclusion
- \*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\*
- Male and female Active Duty members and DoD beneficiaries
- Age 18 years or older
- Chronic debilitating pain
- PROMIS-57 T score is 60 or above
Exclusion
- Pregnant
- Implanted pacemaker
- Spinal cord stimulator
- Illicit drug use including marijuana use
- Epilepsy or a history of seizures
- Other implanted device (e.g., insulin pump, opioid pump, or defibrillator)
- Chronic debilitating pain referred or recruited as measured by PROMIS-57 T score is below 60
Key Trial Info
Start Date :
December 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04011176
Start Date
December 9 2019
End Date
June 1 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mike O'Callaghan Military Medical Center
Nellis Air Force Base, Nevada, United States, 89191